Episode Synopsis "The Benefits and opportunities of entering the UK Market with MedTech Post Brexit & Successful Case Studies"

This webinar featured an impressive group of panellists, including:-Michael Branagan-Harris, CEO, Device Access-James Lindley, Commercial Counselor, US Embassy London-Jeff Dillon, UK Dept International Trade DIT-Amit Kukreja, Vice President | Corporate Market Access & Reimbursement at MasimoFormer Vice President, Global Marketing, Reimbursement and Patient Access at Second Sight Medica. Products-Dawn Smiles, Founder and Clinical Director at MedTec Consulting Ltd-Michael Kujak, Former Chief Marketing Officer & SVP International Commercialization NxThera Inc-John West, Director, Pellere Health

Listen "The Benefits and opportunities of entering the UK Market with MedTech Post Brexit & Successful Case Studies"

More episodes of the podcast Device Access UK Ltd's Podcast

• MedTech Opportunities in 2022 as NHS Hospital Waiting List Pressure Grows
• How the NHS Carbon Neutral Agenda Affects the MedTech Industry
• MedTech Opportunities as NHS Hospital Waiting List Pressure Grows
• How to successfully navigate UK NHS procurement and tendering for MedTech
• The Benefits and opportunities of entering the UK Market with MedTech Post Brexit & Successful Case Studies
• Accelerating MedTech Evidence Generation with the NIHR
• The Use of Real World Evidence to Accelerate MedTech HTA Approval
• How to Accelerate MedTech Sales into UK Private Hospitals
• The Power of the Patient's Voice in NHS MedTech Adoption.
• Value Based Healthcare Solutions for MedTech
• Reducing Your Investment Risk in Start-Up MedTech
• Accelerating MedTech Adoption into the NHS
• Understanding NICE and MedTech Evaluations
• Re-Opening of Elective Surgery in the NHS
• NHS MedTech Market Access Engagement Post Covid 19 Series